Addiction MedsAlcoholDisordersMed-PsychResearchSubstance UseHow to Personalize Meds for Alcohol Use DisorderJuly 23, 2026by Chris Aiken, MD0
AntipsychoticsDisordersOCDResearchGuidance and Misguidance in the New OCD GuidelinesJuly 15, 2026by Chris Aiken, MD0
Addiction MedsAlcoholCannabisDisordersMethamphetamineOpioidsResearchSedativesSubstance UseNew Guidelines For Substance Use DisordersJuly 12, 2026by Chris Aiken, MD2
AntidepressantsDepressionDifficult to Treat DepressionMedicationsNeuromodulation/TMSResearchTherapyTop ResearchAnhedonia in Major Depression: An Expert ConsensusJune 19, 2026by Chris Aiken, MD2
CannabisChild PsychiatryDisordersResearchSchizophrenia and PsychosisSubstance UseTherapyNew Guidelines for Psychosis PreventionMay 28, 2026by Chris Aiken, MD0
AntipsychoticsClozapineGLP1 AgonistsResearchSchizophrenia and PsychosisSchizophrenia Guidelines OverhauledMarch 24, 2026by Chris Aiken, MD0
DepressionDifficult to Treat DepressionResearchAn Algorithm for Late-Life DepressionMarch 23, 2026by Chris Aiken, MD0
AntidepressantsGeriatric PsychiatryMed-PsychSSRIs and Bleeding Risk: Expert GuidanceMarch 23, 2026by Chris Aiken, MD0
DeprescribingGeriatric PsychiatryMedicationsResearchTop ResearchWhen to Stop: An Expert Consensus on Deprescribing PsychotropicsMarch 11, 2026by Chris Aiken, MD0
AntipsychoticsMedicationsSchizophrenia and PsychosisTop ResearchA Global Algorithm for SchizophreniaMay 12, 2025by Chris Aiken, MD0